Fundraising tips

Gift Aid

If you would like to make a donation and are a UK taxpayer you can Gift Aid your donation. Gift Aid gives CPT an extra 25p for every £1 you donate! Read more

Social media

Social media is a great way to raise awareness of your fundraising activity or challenge and it is also a powerful tool for raising awareness of The Cure Parkinson’s Trust. Read more

If you are taking on fundraising challenges or organising an event, it’s worth finding out about any local ‘What’s On’ guides and publications (in print/online). Local radio websites sometimes have events calendars which enable you to add yours. Read more

Fundraising Pack

Download our fundraising pack, full of ideas of how to get your fundraising started! Read more

Latest

Join Our Virtual Rallying to The Challenge Meeting – ‘When and How Does Parkinson’s Begin?’

For the first time, this year's meeting for people with Parkinson's, will be held online and will focus on the origins and development of Parkinson’s, including triggers, early symptoms and stages of the disease. Register now...

Prasinezumab shows signs of slowing motor symptom decline in early stage Parkinson’s

Earlier this year the results of a major clinical trial - called the PASADENA study - were announced. The study was testing an immunotherapy treatment targeting alpha-synclein in people with Parkinson's. The results indicated that the trial had not achieved a positive result based on a predetermined measure of success, but the investigators indicated that there were ‘signals of efficacy‘ in the data and some of these were shared at the 2020 Movement Disorder Society meeting.

The John Black Charitable Foundation joins International Linked Clinical Trials programme as third funding partner

The Cure Parkinson’s Trust (CPT) and Van Andel Institute (VAI) are delighted to welcome a third strategic funding partner, The John Black Charitable Foundation (JBCF), to the International Linked Clinical Trials (iLCT) programme. Together, these three partners have pledged a total of USD $6.75 million to Parkinson’s research, over three years.

The PD-STAT/Simvastatin study results

This week the results of a large Cure Parkinson's Trust-funded clinical trial were released. The PD-STAT study was a UK-wide, Phase II clinical trial evaluating the disease modifying potential of the cholesterol-lowering drug simvastatin in people with Parkinson's. The results indicate that the treatment does not have any impact of the progression of the condition.

Breakthrough in stem cell treatment for Parkinson's

In a major breakthrough for the treatment of Parkinson's, researchers working with laboratory rats show it is possible to make dopamine cells from embryonic stem cells and transplant them into the brain.

Tom Isaacs

We are devastated to announce that Tom Isaacs, President and Co-founder of The Cure Parkinson’s Trust (CPT) died on Wednesday morning (31st May). Tom’s passing was unexpected and swift.

New Evidence Suggests Parkinson's Might Not Start in The Brain

A new study adds to a raft of new evidence which suggests Parkinson's starts in the gut...

Science news

Read the latest Parkinson's science and research news here.

Trials - Repurposed Drugs

Our International Linked Clinical Trials initiative (iLCT) identifies potential new treatments to slow, stop or reverse Parkinson’s disease by 'repurposing' or repositioning drugs that are approved to treat other conditions.

Apply for Funding

The NAC Trial - the facts

Our story

Diabetes Drug Potential Disease-Modifying Therapy

The study, published in The Lancet and funded by The Michael J. Fox Foundation for Parkinson’s Research (MJFF), supported by CPT found that people with Parkinson’s treated with Exenatide for one year performed better in motor tests than those on placebo.